ABSTRACT The use of serum antibodies to neutrophil cytoplasmic antigens (ANCA) as a diagnostic marker for Wegener's granulomatosis and other forms of vasculitis has been assessed. Although ANCA have been described by several groups the precise antigenic targets are unknown, and detection of ANCA still relies on an indirect immunofluorescence assay technique. Several different patterns of fluorescence have been produced by using sera from different groups of patients, and insufficient information is available on the frequency of positive results and of the patterns of immunofluorescence obtained when serum from patients with vasculitis as a part of a generalised connective tissue disease is used. A study was carried out on serum from 240 patients, including 23 patients with Wegener's granulomatosis, 12 with microscopic polyarteritis, and 30 with various connective tissue diseases. Three patterns of fluorescence were observed: bright coarsely granular cytoplasmic, bright non-granular cytoplasmic, and weak diffuse cytoplasmic. The bright, coarsely granular pattern was 86% specific for Wegener's granulomatosis in this series and was observed in 18 of 23 cases. Other patterns of fluorescence were found in various conditions and were not of diagnostic value. The technique is simple, inexpensive, rapid, and reproducible.
Introduction
Wegener's granulomatosis is classically defined as a necrotising granulomatous vasculitis in the upper and lower respiratory tracts associated with focal and segmental necrotising glomerulonephritis.' The classical features are frequently absent, however, and diagnosis is therefore delayed.
The recognition ofautoantibodies directed against a neutrophil cytoplasmic antigen (ANCA) in Wegener's granulomatosis23 has led to hopes of a specific diagnostic marker for this disease. ANCA may also be useful in monitoring disease activity,23 particularly when used with measurement of C-reactive protein. 4 It is clear that ANCA represent a group of different antibodies as different patterns offluorescence may be obtained from different serum samples.5 The original description described bright, granular fluorescence of the neutrophil cytoplasm in an indirect immuno-fluorescence assay as diagnostic of Wegener's granulomatosis.2 ANCA have, however, been described in microscopic polyarteritis,67 Kawasaki disease,8 Churg-Strauss syndrome,9 and even carcinoma of the lung.'0 In microscopic polyarteritis, where the pattern of fluorescence has been specified,67 a bright, diffuse cytoplasmic fluorescence has been recorded.
This study investigates the pattern of fluorescence produced by ANCA in serum samples from patients with a wide range of diseases, and assesses the clinical value of detecting ANCA by an indirect immunofluorescence assay.
Methods

IMMUNOFLUORESCENCE ASSAY
The assay used is a modification of that described by Van (fig 2) .
As the fluorescence score decreased the range of diseases with detectable ANCA increased. The inclusion of patterns other than the very bright 375 granular cytoplasmic fluorescence therefore resulted in reduced specificity of the assay.
ANCA were readily detectable in neutrophil cytospin preparations stored for up to five weeks. This allows the preparation of large batches of fixed slides, which is convenient if the test is to be performed rapidly as a diagnostic aid when required. Repeated freeze-thawing of serum samples resulted in a reduction in ANCA fluorescence, but samples stored for four years at -70°C retained fluorescence.
As serum giving a coarsely granular pattern was diluted we noted that the pattern of fluorescence changed to diffuse before the fluorescence signal actually disappeared. This change occurred at a serum dilution of 1:80 in one case, at 1:160 in most cases, and at 1:500 in only two cases. Repeat samples from patients having treatment sometimes showed a similar change in pattern of fluorescence from granular to diffuse, irrespective of the titre of antibody used.
The titre of antibody fell in parallel with other markers ofdisease activity, such as the white blood cell count, erythrocyte sedimentation rate, and serum concentration of human neutrophil elastase." With recrudescence of clinical disease, such as mouth ulceration, lung cavitation, or deteriorating renal function, the titre of ANCA increased.
Discussion
The classification of vasculitis is difficult and at times unclear.'2 Primary vasculitis is generally accepted as having an immunological basis, probably with immune complexes damaging the vascular wall.' The diagnosis of Wegener's granulomatosis is frequently delayed because of the difficulty of obtaining definitive diagnostic material.7'3 The discovery of ANCA (a generic rather than a specific title), which are thought to be specific for Wegener's granulomatosis, was therefore hoped to be an important advance in the recognition of this disease and its differentiation from other vasculitides, in particular microscopic polyarteritis.24 The reported sensitivity of ANCA tests for active Wegener's granulomatosis has varied from 71% to 100%,24 which is similar to the 78% in our series. We have found ANCA in a few cases of microscopic polyarteritis and Churg-Strauss syndrome but our specificity of 86% for Wegener's granulomatosis is high, and similar to the range of 88-100% reported in other series.24'014 The precise figure for specificity is likely to vary a little as it will be influenced by the composition of the control group. These results are equivalent to accepted values for anti-double stranded DNA antibodies in systemic lupus erythematosus and antiacetylcholine receptor antibodies in myasthenia gravis.4 In addition to the very bright, granular cytoplasmic fluorescence that we regard as characteristic of Wegener's granulomatosis many samples had ANCA Harrison, Simpson, Kharbanda, Abernethy, Nimmo activity, albeit with less intense and diffuse fluorescence, including serum from four patients with Wegener's granulomatosis, six patients with microscopic polyarteritis, and two patients with ChurgStrauss syndrome. Other groups have reported diffuse fluorescence and have included this pattern under the title of ANCA.2 It seems likely that more than one antigen is recognised by ANCA'5 and the pattern of fluorescence may relate to the antigen or antigens recognised by the antibodies present in the serum.'6 Many cases of connective tissue diseases as well as several cases of Paget's disease of bone were included in our study group. Diffuse, weak ANCA fluorescence has been described in serum from patients with primary biliary cirrhosis," rheumatoid arthritis,'4 bronchogenic carcinoma,'0 and viral enteritis.'°The meaning of these findings is not clear but they suggest that antibodies to neutrophil cytoplasmic antigens are a heterogeneous group of antibodies directed against different antigenic determinants and not a single entity. In cases ofmixed connective tissue disease there is a well described antibody to extractable nuclear antigen.'8 Our present findings of cytoplasmic fluorescence in this condition may be the result of artefactual displacement of nuclear antigen during preparation of neutrophils for cytospin, in a way similar to the proposed displacement of nuclear c-myc oncoprotein during tissue fixation from the nucleus to the cytoplasm.'9 Patients with Wegener's granulomatosis do not usually have other specific autoantibodies. 4 The weak ANCA fluorescence found in cases of Paget's disease of bone are of interest. Lockwood and colleagues6 have proposed that the target antigen of ANCA in vasculitis is an epitope (antigenic determinant of known structure) derived from alkaline phosphatase, though this is controversial.""' If alkaline phosphatase is an autoantigen, then ANCA may be a epiphenomenon related to increased serum concentrations ofthe enzyme as a result ofneutrophil degranulation. In Paget's disease the serum concentration of bone alkaline phosphatase is raised, so possibly ANCA are the result of cross reactivity between epitopes ofbone and neutrophil alkaline phosphatase.
A similar argument may apply to similar antineutrophil cytoplasm fluorescence detected in cases of primary biliary cirrhosis. '7 In these cases the fluorescence is weak and difiuse, similar to that seen with rabbit anti-human alkaline phosphatase antiserum. 2' In conclusion, the presence of ANCA giving bright granular cytoplasmic fluorescence is of considerable value in suggesting the diagnosis of Wegener's granulomatosis and, to a lesser extent, of some other vasculitides. The indirect immunofluorescence assay is rapid, reliable, reproducible, inexpensive, and within the capabilities of most laboratories. Further identification of the antigenic epitopes concerned may Neutrophil autoantibodies in Wegener's granudomatosis increase both the specificity and the sensitivity of testing for ANCA in the diagnosis and follow up of Wegener's granulomatosis, and increase our understanding of the underlying disease process.
